| Filed On | Filing |
|---|---|
| 19 Mar 2021 |
8-K/A: Other Events
CAMBRIDGE, Mass., March. 18, 2021 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage biopharmaceutical company on a mission to develop treatments that restore cognitive function, today announced that Christ... |
Loading...